Senphonix
Senphonix
  • Home
  • Products
  • Applications
  • Team
  • Contact
  • Investors
  • More
    • Home
    • Products
    • Applications
    • Team
    • Contact
    • Investors
  • Home
  • Products
  • Applications
  • Team
  • Contact
  • Investors

STARTING WITH REVOLUTIONIZING HOW VITAL SIGNS ARE TAKEN

SleeveSense™ is fueled by University of Arizona Technology. It’s an adhesive-free, mesh vitals sleeve that wirelessly charges and captures continuous clinical-grade biosignals data, seamlessly integrating with Senphonix's Microsoft Azure HIPAA-compliant cloud via encrypted Bluetooth® or LoRa® communication protocols. It's designed to be worn for days, weeks, or months without the need for removal during exercise, bathing, sleeping, etc. Comfort and durability have been prioritized to enable seamless integration into patients' lives, simplifying the process of measuring vital signs such as heart rate, respiration, blood pressure, oxygenation, perspiration, temperature, motion, and more, depending on the needs of the wearer.


Encrypted biosignals data flows continuously or in batches from the SleeveSense device to an Internet router and then to the Senphonix cloud. From there, data is analyzed to detect out-of- range patient vital signs, which then lead to clinician alerts, either via the Senphonix user interface, the patient's electronic health record (EHR), or both, in all cases showing up as a text or in-app notification. 


The clinician interface, whether inside or outside of the EHR, will include the ability to configure alerts to the clinician's preference, a dashboard, alert history, and full reporting.

  "Telemetry is helpful, but it’s bulky and only works in certain units."


"We already use wearable patches, but they don’t talk to our system."

Together, SleeveSense and the Senphonix cloud will provide a secure environment to collect, ingest, and analyze patient biosignals. From there, patients' healthcare providers will see valuable alerts and reporting. A few of the key benefits of the system include: 


  • Automation eliminates the need to disturb patients or consume valuable nursing resources
  • Continuous, long-term flow of vitals data provides clinicians a better view of overall patient health
  • Wireless communications eliminate the need for cables and bulky equipment
  • EHR integration provides an easy path to import charting data
  • When wireless connectivity isn’t possible, data is queued, not lost
  • Comfortable design means patients can wear a single sleeve for months
  • Lack of adhesives and straps prevents damage to skin, especially important for elderly patients who are sometimes prone to skin tears
  • Wireless recharging allows carefree, constant monitoring, without hassle
  • Charging station is compact, enabling use in hospitals, outpatient environments and at home
  • Pay-as-you-go pricing model eliminates the need for capital investment

Patient Health Information is Treated with Extreme Care

When implementing with Bluetooth Low Energy (BLE), Senphonix will use it with Secure Connections enabled (Bluetooth 4.2 or later), leveraging AES-128 encryption with Elliptic Curve Diffie-Hellman (ECDH) key exchange for strong authentication and data confidentiality. Data transmitted from the Bluetooth receiver to the Azure IoT Hub or Event Hub will be secured using TLS 1.2 or 1.3.


For LoRa implementations, data from the device to the LoRa gateway will be encrypted using LoRaWAN 1.1 or later with AES-128 encryption—AppSKey for payload confidentiality and NwkSKey for message integrity. Data from the gateway to the LoRaWAN network server, and then to the Azure IoT Hub or Event Hub, will be transmitted over TLS 1.2 or 1.3 for secure transport.


Regardless of the implementation choice, once in Azure, data will be encrypted at rest with AES-256 and in transit with TLS, with proper access controls and key management via Azure Key Vault.

 “As long as it’s HIPAA compliant and the data is secure, I’m on board.”

"This is the kind of thing nurses have been hoping for." 

SleeveSense™ is expected to be available after FDA evaluation.


Senphonix is a Delaware C-corp., with offices in Minnesota and Arizona. For more information, contact us at info@senphonix.com, or follow us on LinkedIn. Copyright © 2025 Senphonix, Inc. - All Rights Reserved. Logos and trademarks are the property of their respective owners. All quotes herein are drawn from anonymous responses to a national survey of licensed nurses conducted by MarketWise Advising in 2025; some were lightly edited for brevity. 

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept